Glucagon-like Peptide-1 receptor agonist differentially affects brain activation in response to visual food cues in lean and obese individuals with type 2 diabetes mellitus
Oezer, K
For sermorelin, ongoing studies could focus on its long-term effects on growth hormone optimization, anti-aging properties, and muscle preservation in aging populations
PMID: 14 HotamisligilGS
A peptide triple agonist of GLP-1, neuropeptide Y1, and neuropeptide Y2 receptors promotes glycemic control and weight loss
[DOI] [PubMed] [Google Scholar] 32.Anker S.D., Butler J., Filippatos G., Ferreira J.P., Bocchi E., Bhm M., BrunnerLa Rocca H.-P., Choi D.-J., Chopra V., Chuquiure-Valenzuela E., et al